Minimally invasive surgery for small bowel neuroendocrine tumors shows significant benefits over open resection.

• MIS resulted in 54% lower odds of postoperative complications.
• Patients had shorter hospital stays (4 vs. 6 days) and fewer infections: skin/soft tissue (2.1% vs. 6.8%), urinary tract (0.5% vs. 2.4%), sepsis (0.2% vs. 1.2%).

This approach enhances short-term outcomes and should be considered when oncologically appropriate.